Coloplast A/S (OTC Pink - Limited Information:CLPBY)
| 11.74 Delayed Data As of Nov 28 |  -0.015 / -0.13%Today’s Change | 9.90 Today|||52-Week Range 14.77 | +0.95% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Operating Activities | Net Income / Starting Line | 207.1M | 215.5M | 198.3M | 203.2M | |
| Depreciation | 25.0M | 23.6M | 24.2M | 24.5M | ||
| Total Other Cash Flow | -17.0M | -8.7M | -129.8M | -49.2M | ||
| Funds From Operations | 215.1M | 230.3M | 92.7M | 178.5M | ||
| Funds From/For Other Operating Expenses | -7.9M | -13.0M | -25.4M | 108.8M | ||
| Net Cash Flow - Operating Activities | 223.0M | 243.4M | 118.1M | 69.7M | ||
| Investing | Decrease In Investments | 1.6K | -11.3K | 917.5K | -613.2K | |
| Capital Expenditures | -29.7M | -18.6M | -17.1M | -18.9M | ||
| Fixed Asset Disposal | 328.6K | -31.0K | 1.7M | 4.6M | ||
| Net Assets From Acquisitions | -120.6K | 826.3K | -- | 0.00 | ||
| Net Cash Flow Investing | -31.4M | -21.4M | -17.4M | -17.6M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | -- | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | -- | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 37.9M | 21.6M | 5.2M | 11.1M | ||
| Common Preferred Redeemed | -49.1M | 1.4M | 0.00 | -14.5M | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -172.8M | 9.1M | -357.2M | 1.8M | ||
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -237.3M | -183.5M | -80.3M | -72.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | 2.0M | |
| Net Change In Cash | -45.8M | 38.5M | 20.3M | -20.0M | ||
